NEUROMERSIVE, INC — Department of Defense SBIR Phase I: AFX235-CSO1

NEUROMERSIVE, INC — SBIR Phase I award from Department of Defense.

Amount
$74,774
Agency
Department of Defense · Air Force
Program / Phase
SBIR · Phase I
Topic
AFX235-CSO1
Solicitation
X23.5
NAICS
Place of performance
TX
Period
2023-05-19 → 2023-08-21

Description

Our proposed solution involves adding vestibular condition physical therapy capabilities to Neuro Rehab's XRTS product using Immersive Virtual Reality. The solution will enable enhanced vestibular condition monitoring and treatment, which is crucial for p